. Cristal therapeutics. ASX - General. 6¢. Deliver ZERO dividends, a NEGATIVE capital return and depressed share price to shareholders over a 17 year period. . Market . Follow your favourite stocks, view charts, track. . The Company is. While the chart is not good there is a glimmer hope maybe emerging. Hi all, I think it would be in all of our best interests if each of us sent an email to SPL investor relations and voiced our concerns. Expanding claims in UK- hmmm it would be a gamble by SPL to choose to put up that option rather than continue as is as MHRA may have same questions TGA has got ( whatever exactly they are) that don't seem to be resolved. Click for more information. Charts. You got to wonder after huge volumes going through last 4 days and the SP reaching new lows. $0. Since then. 8. . 48. Despite the length of time that SPL has been in existence, it is obvious that some players think that SPL is currently overvalued, hence the relentless selling. HotCopper has over 250,000 registered members, and more than 200,000 unique visitors every month and a huge 21 million monthly page impressions. 75. LEADING THE BATTERY METALS REVOLUTION. Based on SPL's announcements and on reports of the AGM, my opinion is that the tune of the song that SPL sings never changes. . m. Model # 407730 Store SKU # 1000846365. 367026. Share Interesting and positive early pre-clinical results. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Some links within this article worth a scan too. Created with Sketch. ASX - By Stock. Still waiting for you @antibotter to explain why it appears you tried to influence newbies and less experienced investors into thinking that something big was imminent based on a comment in the SPL newsletter. So much coming up with Viraleze and DEP Starpharma team will be working very hard at the moment with so many balls in the air. Charts. I'd think that SPL will be covering all the bases required for a crack at 505b2, but with the necessary data to pivot to a phase 3 trial if. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . ASX - Short Term Trading. 8985. ASX - Day TradingMelbourne, Australia; 8 December 2022: Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announces that it has commenced recruitment in the UK for a post- market clinical study of its broad-spectrum antiviral barrier nasal spray, VIRALEZETM, in patients with COVID-19, following receipt of the necessary regulatory and ethics. Forums. Created with Sketch. 06 Sentiment: Buy Disclosure: Held Created with Sketch. DYOR Why am am I still positive well let's go through my path to here in 2016/17/18 I was buying shares I bought one package of 100,000 for 66 cents and ended. Commodities. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . rights. 57% 13. Click for. 0¢. SPL - still awaiting human trials!Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Last updated 15. Created with Sketch. Join the HotCopper ASX share market forum today for free. 6. I recommend that everyone sees the below. Hey, "smart", I concur with your message. ASX - Day Trading SUBMISSION STEPS. And it’s at least good to see that the ASX has demanded supplementary information from Starpharma on numerous occasions recently. 4¢. Viraleze being 1% less efficacious against the more potent dangerous new strains is an awesome result and should be celebrated. Enquire Now & Supercharge Your Brand with HotCopper 17 Oct 2023. ASX - By Stock Forum | Join the HotCopper forum today for free. Last updated 15. ASX - Short Term Trading. This extract caught my eye"The AstraZeneca programs involves $US124 million of milestones, about half of which are “relatively near”. 0012. In summary, there appears to be a massive financial incentive ($7m per year) for SPL to keep turnover below $20m, until such time as sufficient progress has been made on all fronts for profitability to become a. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 5¢. Once they think they can get AZD0466 to market they will pounce if our share price is less tan $2. Latest Posts. Market . 3¢. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Our magic little formula may just be the answer. Click for more information. Just as I thought - both @antibotter and JF & Co. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. ”For your information 55% of the company is held by institutions” ~ AB I. Quarterly Activities Report & Appendix 4CLooking further into the AGM notice, Resolution 3 is a massive slap in the face to share holders!!!Basically the company is proposing to dish out a bonus. 6% (1. All the case studies have already been touted by SPL in various ASX announcements and the only trial that is declared finished by Starpharma and scheduled for readouts is DEP. Time to put your feet up and kick back for a while. Application for quotation of securities - SPL. Hotcopper has reinvented itself as The Market Herald with an ASX code of TMH The company has an online news site called The Market Herald Below is a. 0. Antibotter despite you starting 23 separate Starpharma threads in 3 weeks you do not own this Hotcopper forum. 2. Join the HotCopper ASX share market forum today for free. The results will be good but will they be good enough for SPL to be able to do the deals. Share Many media conferences during the Pandemic we heard of Victorian initiatives for covid treatments or preventative by Dan Andrews or Brett Sutton - so VICTORIA has questions to answer. . And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Share Given the current status of Starpharma, I am surprised any of these made it through from 2020 but it appears 121,082 did. Created with Sketch. Forums. The borders are now open Look forward to a positive outcome with new partnership agreements permeating from our team networking at ASCO. Friday 26/06/2020 looks like the slide deck is very similar if not identical to last Friday's audio presentation I will be recording audio just in case this audio presentation is differentSPL management team get bad marks for delays all the time but I don’t read anyone citing possible reasons. Created with Sketch. SPL conducts a "trial" (use that word loosely) in of all places WA !! Yet our commercial hotshots cannot arrange a deal with a WA based company who appear highly capable and connected in getting distribution to sought after sectors like "Allied Health practitioners, the corporate sector and government". June 9 (Reuters) - Starpharma Holdings Ltd (SPL) : STARPHARMA CEO TO RETIRE IN 2024 FOLLOWING SIGNIFICANT TENURE AS COMPANY'S CHIEF EXECUTIVE OFFICER. $0. ASX - Day Trading. SPL. 76. Maybe SPL is frustrated at the lack of promotion, or maybe they have frustrated McKesson with continuity of supply, but I doubt it this early in the relationship - the logistics will be guided by demand, and it takes time to find the right equilibrium without overcommitting funds and/or scaling up manufacturing capacity, honouring contracts etc. Eight (8) contributors to the HC SPL thread made price predictions (thank. ASX - Day Trading. 45K. 8327/7/2021 SPL $1. Created with Sketch. . Latest Posts. News: SPL Starpharma Holdings Appoints Cheryl Maley As CEO & Managing Director: 10/11/23 : 0: 94: 10/11/23: Last post Hot News: Created with Sketch. A trader who used stock forum HotCopper to pump and dump about 20 penny stocks using 13 trading accounts has been given a jail term of 2½ years, but is being released immediately on a five-year. and as I said I met @Domesticgod there, which was a pleasure. The purpose of many of us working in pharmaceutical research and development whether within the industry or academia is to deliver medicines to improve the lives of patients around the world. But I’ve been having a. SPL is not a penny dreadful (not yet anyway) and it is not a resources company and it has enough funds to last a few more years even if it never makes a cent. 00%. Last updated 10. Your statement below masquerading as a fact could mislead less experienced investors on this Hotcopper forum. Created with Sketch. I can't guess where or what or when, perhaps there is an informed opinion out there in HC SPL land but we have a very tight market and some. Last updated 15. 15667. ” This, sadly, is not true. Canadian Dollar. 8985. municipal. 36pm 23/11/2023 ? HotCopper has news, discussion, prices and market data on SPARC TECHNOLOGIES LIMITED. Taking Cols scenario for a sting like buyout if the buyout price is higher than the highest price the company has reached there is no avenue for complaint. Volume. Altech Batteries (ASX:ATC) has confirmed its Silumina Anodes project can be eight times larger than previously thought. Starpharma is a world leader in the development of new medical products based on its proprietary dendrimer technology and has partnerships with leading global companies, including AstraZeneca, MSD (Merck & Co. Jackie Fairley says: “Clearly we are surprised and extremely disappointed. SPL polylycine dendrimers are proving to play a major role in the future of ADC’s. ASX - Day TradingAnyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. ” ~@sarge17 Last edited by sarge17 : 24/02/23 SPL Price at posting: 54. Or primary care stop like a medical centre or clinic- stating the obvious- hope SPL have better marketers than I) Also would like to see what the USA have done to allow retail investor to get involved in per IPO rather than just institutions investors getting the huge discount to Share Price. They not even have a license with SPL, just a basic research agreement. See All Discussions. 50 At this stage in the game, I would not accept anything under $5 (fact)Btw if Starpharma do receive an upfront milestone of $300 million for Dep Docetaxel, Dep Cabazitaxel and Dep Irinotecan license, I believe a special dividend will be paid out to all. Created with Sketch. 5. are either confused or talking nonsense. 32 , that is a daily rise of over 50% on the market capital at the time it hit that low. With EOFY selling about to hit us like a freight train, where does everyone think the bottom will be for SPL' shareprice?Unless one of the many promises. Notice to Sellers of Vapour Products – PST Rate Increase to 20% Page 3 of 3 Need more info? Online: gov. TSASC INC N Y 5% 0. 63. . Join the HotCopper ASX share market forum today for free. Comments. Latest Posts. Created with Sketch. 5 years Starpharma has not publicly released any information to the ASX about progress of the partnership. 00%. I am closely watching the state of the World Economy, particularly China and the U. . 0¢. Volume. SPL Price at posting: 44. That won’t be a shock to. Created with Sketch. 59pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on PANCONTINENTAL ENERGY NL. ASX - Short Term Trading. 37pm 10/11/2023 ? HotCopper has news, discussion, prices and market data on WHISPIR LIMITED. 22%) 3,361,416 was the lowest point of total short sales for some years as of 15/06/23 (0. 45K. Latest Posts. ASX - Day Trading. The AGM has come and gone What did we learn from this meeting according to our attendee's who post on HotCopper forum When it comes to. 3¢. 0000. HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. Come on SPL, complete these trials for the Companys sake, the shareholders sake and all the people out there suffering from these cancers. They are the future as also mentioned regularly by Eric Topol. No China virus, no Flu, no colds. Created with Sketch. 38. . So SPL did the one thing they could to challenge the TGA they sent it to adjudication and TGA were told Feb 22 - you must accept application as medical device and SPL announced to ASX in April 22 that their application was in. Advertise on HotCopper. There appears to be a different behavioural feel about. The Scripps in-vivo evidence using genetically engineered mice only became available to the November TGA conference at which such matters are. The total and absolute shame of this is that not once in their quarter of a century of existence have these "discussions" amounted to a deal. 1. ASX - Day TradingHi guys, I have held SPL shares for over 9 years and I will continue to hold. 0834. Both were very well paid and, if the "forward looking statements" are to be believed would have had the box seat in a company with a great future. Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat. 8. Check out the spin on this promo---One ASX company Set to Revolutionise the $112 BILLION Cancer-Drug MarketBy: Adam SurpliceIndustry experts expect that. 37. Starpharma (SPL) Shares in the nano-biotechnology group bucked the falls in the wider market on Monday after it announced a deal with a division of US pharmaceutical giant Ely Lilly to extend the application of its technologies in the animal health area. Some have been mentioned on this thread previously. If only we had the viraleze. Last updated 14. Market Dep Cabazitaxel will be licenced out before initiation of Phase 2 clinical trial (in other words this year. 68. We, as investors in this company deserve to knowmore. AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Nope. 83453. I've been a SPL shareholder since Nov 2015 when I bought a small parcel at 91c. The bait SPL have put out about models and publishing in 3 weeks should be stopped by ASX / ASIC and teh timing is odd IMO. most else of the list is same as we want to happen years ago and long long overdue. . The thread is titled so that it can be found and general enough so as to. . 5¢. Commodities. ASX - By Stock. Join the HotCopper ASX share market forum today for free. $0. Join the HotCopper ASX share market forum today for free. Virtual investor presentation Tomorrow night Starpharma will be Participating in a virtual investorpresentation on the OTC website for those that are. Hey, "smart", I concur with your message. Advertise on HotCopper. Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable. Interesting write-up. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 13. 8¢. Created with Sketch. Change in substantial holding. SPL. Join the HotCopper ASX share market forum today for free. ASX - By Stock. Some links within this article worth a scan too. Volume. Created with Sketch. HotCopper has news, discussion, prices and market data on SOUTHERN CROSS PAYMENTS LTD. Market. 06B ! Add to my watchlist. - 12:30 p. GLTAH but for me SPL is still a strong AVOID until a development of substance is announced. 0. Market Cap $55. . ASX - By Stock. 14. We would like to show you a description here but the site won’t allow us. Created with Sketch. 54pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on BETMAKERS TECHNOLOGY GROUP LTD. It would be nice to have SPL make an announcement to the market to clear up the uncertainty around the many market sensitive announcements made that seem to have just faded into the background with no update as to whether they are progressing or if they have ceased. 6% downward extention down to (0. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Feb 28 (Reuters) - Starpharma Holdings Ltd (SPL) : HY REVENUE FROM CONTINUING OPERATIONS DOWN 16% TO A$1. 9¢. Energy. Join the HotCopper ASX share market forum today for free. Enter the title of your abstract. 30. Click for more information. This is just a lifestyle company at this point, management just keeping the company afloat with announcements that have no tangible impact on the share price while they collect their salaries. ASX - Day TradingDoes Spl deserve to be seven times less in mkt cap to another biotech that has one phase 2 product spl potentially 3 and commercialisation deal with astra zeneca and collaboration deals with Merck and Genentech. Why am am I still positive well let's go through my path to here in 2016/17/18 I was buying shares I bought one package of 100,000 for 66 cents and ended. Everyone holding SPL shares should now realise that unless they can have a deal signed on at least one of the Dep candidates within 3 to 6 months with a substantial. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. StarPharma Holdings Ltd. However, I think that maybe SPL is occasionally worth a swing trade gamble. ASX - By Stock. Market Cap $58. You not understand how clinical trials works - it takes years to build regulatory packanage and do CMC. Altech Batteries (ASX:ATC) has confirmed its Silumina Anodes project can be eight times larger than previously thought. . ASX - Day TradingLast day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sellThe deal, which has an initial duration of 12 months, has the same terms as the previous agreement. The reason I loaded up in the year post the last agm was because we we falsely told that vivagel would would be launched in Q1. We had a Dec 2021 DCB of around the FIB 23. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Right size, can penetrate deep into tumour tissue, right architecture, hang around long enough to do the job, soluble so the. . ASX - By Stock. Hey, "smart", I concur with your message. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Just wondering if anyone else took the time to report Starpharma to the ASX as I did? Remember, NOTHING will ever change if CEOs and Directors of public. . It is a real eye opener and paints the Pharmaceutical Industry in a very bad light. NEVER - there should be an official corruption enquiry considering the Gov Funding and R&D reimbursements recieved by SPL and what actually was achieved and why they haven't been succesful - there's US companies flogging Povidine Iodine nasal spray and throat sprays left right and centre. 0¢ Sentiment: Hold Disclosure: Held Share Hi Folks Time to revisit the SPL Weekly chart. FORTESCUE METALS GROUP LTD. 0. Share Interesting points John Some institutions might accept anything over $1. . I look forward to holding SPL at task - this will be the third time I have been involved in pushing for a shareholder class action, which I can say on the previous two occasions resulted in a more communicative and transparent company, which ultimately is what I. Extract taken from recent interview with CEO of Starpharma Does it surprise you that big pharma hasn't come in and swooped in and bought the business to. The thread is titled so that it can be found and general enough so as to. IMO they haven't . 72. Below are 3 charts showing the predictions for Starpharma's Price by End 2019. Created with Sketch. HotCopper has news, discussion, prices and market data on PROTEOMICS INTERNATIONAL LABORATORIES LTD. When it goes to 62 cents, and it will as it's 1 cent away, it will be a 282-week low, or 5 years 8 months since it's been at that level, that's a lot of holders if not all on them in the red. RDN Raiden Resources secures complete control of lithium at Arrow Project, buys out Arrow Minerals Ltd. Follow your favourite stocks, view charts, track gainers and losers and discuss topics including politics, commodities, cryptocurrency and managed funds. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Share Yes, this is pre-clinical data, HOWEVER, on this occasion this positive data (of adding Starpharma’s conjugate to IO drugs) directly supports commercial negotiations for the soon to be released top-line results for DEP-Irinotecan, in my opinion. Forums. Market Cap $77. New Zealand Dollar. . 16. Latest Posts. Become a member of Australia's largest investment discussion forum. 3. Market . Created with Sketch. Slow golf clap for Jackie Fairley. . SPL. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Below are 3 charts showing the predictions for Starpharma's Price by End 2019. Just begin to imagine that all staff on board use Viraleze well before. PEG-b-pHPMA-lactate: Docetaxel, microtubule inhibitor/hydrolytic linkerwaste of cash by the time spl manage to do anything with nasal spray covid will have a vaccine if there is one thing spl have deomstrated it is an inability to do anything in a timely fashion. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 2:00 am Eastern Standard Time Australia. ASX - Day Trading So the share price of SPL rose up to a high of $2. 12. SPL has great optionality, potential and a healthy balance sheet to ride out the current storm. Share It is now 2 years and 8 months since CEO Jackie Fairley bought any shares in her own company on-market. Contacts. The goal of the partnership. More. Advertise on HotCopper. ASX - By Stock. 0 Great. ASX - Short Term Trading. Interesting write-up. IMO they haven't . Target our investor community with our suite of. Phillip Altman is a highly-respected and well-known Australian authority on clinical trials and drug regulatory affairs with more than 40 years of experience in designing, managing and reporting of clinical trials and in working with the Australian Therapeutic Goods Administration (TGA) in gaining new drug approvals. ASX - By Stock. ASX - Short Term Trading. ASX - By Stock. Just to refresh people's memory I thought this summed by the exact situation with the TGA and Starpharm STARPHARMA’S COVID-KILLER NEEDS ACTION NOT. . . HotCopper has news, discussion, prices and market data on TRIGG MINERALS LIMITED. Within a post on another SPL thread, sarge17 said: "I wonder what polished horse turd of an announcement we will get from Starpharma in the final days leading up to the AGM. Everyone holding SPL shares should now realise that unless they can have a deal signed on at least one of the Dep candidates within 3 to 6 months with a substantial upfront payment then a CR will definately be on the cards. Since then. Target our investor community with our. There have been so many market sensitive announcements made and then ZEROfollow up on these announcements. We know that they haven't been marketed well but i think BigPharma have had an input. As Waldemar Januszczak said when looking at the portrait of Mr & Mrs Andrews by Gainsborough "THERE IS SOMETHING GOING ON here". Safety, tolerability and side effects appear to be superior to all the base drugs, and that should be enough to sell the licenses. . Latest Posts. . Pre-clinical results from a DEP HER2-Lutetium breast cancer model (see link below) were released by SPL in March 2021 with no update or published advancement since this announcement, and no deal/licence forthcoming. And he still is Chairman or Director of SIX other companies. Charts. AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. Please type the title in sentence case (that is lowercase with only the first letter or the first word in capitals) and without any punctuation. , page-2. Just to make sure we are all on the same page as far as AZD0466 is concerned The data available from the AACR SCLC Abstract (April 19th 2023) was from January 24th 2023 (it is out of date by more than 3 months)Fresh off the press 10th May 2023 The NHL trial is accelerating at a rapid rate Fyi 23 sites recruiting out 29 locations Since last update 8 additional. It is lengthy but well worth the time. SPL have hit road blocks with many of their products. Notification of cessation of securities - SPL. 5 cents. Imo, financial things such as deals, sales and. In summary, my observations about SPL are: Marketing - persistent.